跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MENQUADFI SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MENQUADFI SOLUCIÓN INYECTABLE
Approved
STANDARD
MENQUADFI SOLUCIÓN INYECTABLE
Sanofi Winthrop Industrie
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 17, 2023
Approval ID
4c640e8d6db9b7df
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
4c640e8d6db9b7df
Drug Cima Aemps Name
MENQUADFI SOLUCIÓN INYECTABLE
Register Number
1201483004
Holder Company Name
Sanofi Winthrop Industrie
Marketing Company Name
Sanofi Aventis S.A.
Holder Company Detail Path
/organization/sanofi-winthrop-industrie
Authorization Date
2023-07-17
Dosage Form
SOLUCIÓN INYECTABLE
Dose
0,5 ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi Winthrop Industrie
Company Detail Path
/organization/sanofi-winthrop-industrie
Company Information
Pharmaceutical Company Name
SANOFI WINTHROP INDUSTRIE
Country Name
France
City Name
amilly,centre val de loire,country_fr
Address
130 RUE DE LA FONTAINE
Active Ingredients
ANTIGENO POLISACARIDO MENINGOCOCO GRUPO A
10 µg
ANTIGENO POLISACARIDO MENINGOCOCO GRUPO C
10 µg
ANTIGENO POLISACARIDO MENINGOCOCO GR W-135
10 µg
ANTIGENO POLISACARIDO MENINGOCOCO GR Y
10 µg
TOXOIDE TETANICO
55 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 17, 2023
Approval ID
4c640e8d6db9b7df
Type
Standard
Back to CIMA-AEMPS Approvals